ClinicalTrials.gov
public full text
Public Domain
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of pyrazinamide and/or ethambutol resistance on Tuberculosis treatment outcome by whole genome sequencing, South Africa 2020 – 2022#447668
- Treatment Shortening of MDR-TB Using Existing and New Drugs#834637
- Evaluating Newly Approved Drugs for Multidrug-resistant TB#980001
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment#855887
- Pharmacokinetics and safety of group A and B Anti-Tuberculosis drugs used in treatment of Rifampicin-Resistant tuberculosis during pregnancy and Post-Partum: A narrative review#197711
Record · ID 390944
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive